INVESTORS IR Nav Investor Overview Press Releases Events and Presentations Upcoming Events Past Events Presentations Analyst Coverage SEC Filings Stock Information Stock Quote & Chart Historical Price Lookup Investment Calculator Corporate Governance Governance Overview Management Board of Directors Committee Composition Information Request SEC Filing SEC Filing Details Document Details Form 8-K Filing Date Dec 8, 2020 Document Date Dec 7, 2020 Form Description Report of unscheduled material events or corporate event Filing Group Current Reports Company Protara Therapeutics, Inc. Issuer PROTARA THERAPEUTICS, INC. Filing Formats View HTML Download PDF Download DOC Download XLS IR Tools Print Print Email Alerts Email Alerts RSS Feeds RSS Feeds Email Page Email Page IR Contact Justine O’Malley Vice President, Investor Relations and Communications Phone: 646-817-2836 Email: Justine.OMalley@protaratx.com
SEC Filing Details Document Details Form 8-K Filing Date Dec 8, 2020 Document Date Dec 7, 2020 Form Description Report of unscheduled material events or corporate event Filing Group Current Reports Company Protara Therapeutics, Inc. Issuer PROTARA THERAPEUTICS, INC. Filing Formats View HTML Download PDF Download DOC Download XLS